Pfizer Inc. has secured an exclusive global licensing agreement with 3SBio, Inc., a leading Chinese biopharma, for SSGJ-707.

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

Guardant and Pfizer will use liquid biopsy tests in global oncology clinical trials ... testing capabilities in China through an existing partnership with Adicon Holdings. Feel unsure about ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics ... If those results are positive the partners have said they could file for approval in the ...

and global Pfizer RWE leaders to explore the potential of Abu Dhabi’s Trusted Research Environment in advancing scientific discovery. This initiative is part of a broader effort under the MoU to ...

Through the MoU, Pfizer and DoH are working jointly ... the MoU to foster long-term public-private partnerships that enhance Abu Dhabi’s global competitiveness in biomedical research, genomics ...

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a highe ...

The Business Research Company The Business Research Company's Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – M ...

Vaccine and biotech company SK bioscience announced Wednesday that it the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large ...